ArticleScientific reports2026
The association between food group-based inflammatory score and cardiometabolic disorders in Ganzhou City of China.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
This cross-sectional study systematically evaluated the association between the Food Group-Based Inflammatory Score (FGBIS) and cardiometabolic disorders among adults in Ganzhou City, China. The results demonstrated a significant correlation between FGBIS levels and metabolic abnormalities, with differential distribution patterns observed across sex (P = 0.044) and marital status (P = 0.008) groups. Regression analyses revealed a significant positive association between age and FGBIS, while hypertension status showed an inverse relationship with FGBIS. Gender-stratified analyses further indicated that higher FGBIS levels in males were significantly associated with greater age (β = 0.027), and smoking initiation among non-smoking males substantially associated with higher FGBIS (β = 0.500). In contrast, female hypertensive patients exhibited lower FGBIS levels (β=-0.268). These findings not only reveal distinct demographic patterns in dietary inflammatory effects but also provide important implications for public health practice: targeted anti-inflammatory dietary interventions may effectively mitigate the development of metabolic disorders, and incorporating FGBIS assessment into chronic disease prevention systems could facilitate the development of personalized dietary guidelines, thereby offering scientific evidence for improving population cardiometabolic health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.